Skip to main content

Helius Medical Technologies Inc (HSM-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.36
Day High 1.68
Open:1.39
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Helius Medical Technologies Inc are a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance the brain's ability to compensate for this damage.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Helius Medical Technologies, Inc. Issues a Clarification to the News Release Regarding the Agreement with the University Health Network (UHN) Issued at 7:05 am January 16, 2020
- GlobeNewswire - Thu Jan 16, 3:05PM CST
GlobeNewswire - CMTX
Thu Jan 16, 3:05PM CST
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), would like to clarify that the agreement between the company and the University Health Network (UHN) was between UHN and Helius Medical Inc, a fully owned subsidiary of Helius Medical Technologies rather than with the parent company.
Helius Medical Technologies, Inc. and University Health Network (UHN) Have Signed an Agreement for UHN and three Neuro-Rehabilitation Centers to Perform a Clinical Experience Program of the PoNS(TM) Device in Canada
- GlobeNewswire - Thu Jan 16, 6:05AM CST
GlobeNewswire - CMTX
Thu Jan 16, 6:05AM CST
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announces that it has entered into an agreement with the University Health Network (UHN) to perform a clinical experience program to enable it and three independent neurorehabilitation clinics in Canada to evaluate the Company's Portable Neuromodulation Stimulator (PoNS(TM)) device, in conjunction with physical therapy, on patients with chronic balance deficit due to mild-to-moderate traumatic brain injury ("mmTBI") in Canada.
Helius Medical Technologies Awarded Pioneer Technology Development Award
- GlobeNewswire - Fri Jan 10, 6:05AM CST
GlobeNewswire - CMTX
Fri Jan 10, 6:05AM CST
Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a leading neurotech company focused on neurological wellness, today announced that it is the recipient of the Pioneer Technology Development Award for its development of the PoNS(TM) device. This prestigious award, presented by the Brain Mapping Foundation (BMF) and Society for Brain Mapping and Therapeutics (SBMT), is given to trailblazing technology companies and their CEOs/Presidents who have facilitated the development of pioneering technologies through interdisciplinary approaches that have impacted diagnostics, treatment, and healthcare delivery in unprecedented ways.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.48 +250.00% increase
on 12/18/19
Period Open:0.58
Price movement based on the high, low and last over the given period.
1.75 -4.00% decrease
on 12/24/19
+1.10 (+189.66%) increase
since 12/16/19
3-Month 0.41 +309.76% increase
on 11/22/19
Period Open:2.23
Price movement based on the high, low and last over the given period.
2.25 -25.33% decrease
on 10/17/19
-0.55 (-24.66%) decrease
since 10/16/19
52-Week 0.41 +309.76% increase
on 11/22/19
Period Open:11.25
Price movement based on the high, low and last over the given period.
11.38 -85.24% decrease
on 01/17/19
-9.57 (-85.07%) decrease
since 01/16/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies